Project Details
Description
An Open Label Multicenter Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of SBC-102 in Adult Subjects with Liver Dysfunction Due to Lysosomal Acid Lipase Deficiency Who Previously Received Treatment in Study LAL-CL01
| Status | Finished |
|---|---|
| Effective start/end date | 4/18/12 → 3/14/18 |
Funding
- SYNAGEVA BIOPHARMA CORP.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.